PE20080938A1 - Derivados sustituidos de pirrol - Google Patents
Derivados sustituidos de pirrolInfo
- Publication number
- PE20080938A1 PE20080938A1 PE2007000737A PE2007000737A PE20080938A1 PE 20080938 A1 PE20080938 A1 PE 20080938A1 PE 2007000737 A PE2007000737 A PE 2007000737A PE 2007000737 A PE2007000737 A PE 2007000737A PE 20080938 A1 PE20080938 A1 PE 20080938A1
- Authority
- PE
- Peru
- Prior art keywords
- optionally substituted
- methyl
- pirrol
- cyane
- pyrrol
- Prior art date
Links
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical class C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 title abstract 2
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 2
- -1 4-CYANOPHENYL Chemical class 0.000 abstract 1
- WZKSXHQDXQKIQJ-UHFFFAOYSA-N F[C](F)F Chemical group F[C](F)F WZKSXHQDXQKIQJ-UHFFFAOYSA-N 0.000 abstract 1
- 206010060862 Prostate cancer Diseases 0.000 abstract 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 102000001307 androgen receptors Human genes 0.000 abstract 1
- 108010080146 androgen receptors Proteins 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical group [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003573 thiols Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006163992 | 2006-06-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20080938A1 true PE20080938A1 (es) | 2008-09-02 |
Family
ID=38832218
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2007000737A PE20080938A1 (es) | 2006-06-13 | 2007-06-12 | Derivados sustituidos de pirrol |
Country Status (4)
| Country | Link |
|---|---|
| AR (1) | AR061439A1 (zh) |
| PE (1) | PE20080938A1 (zh) |
| TW (1) | TW200813007A (zh) |
| WO (1) | WO2007145349A2 (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2413504T3 (es) | 2007-12-21 | 2013-07-16 | Ligand Pharmaceuticals Inc. | Moduladores selectivos del receptor de andrógeno (SARM) y usos de los mismos |
| CN103102325B (zh) * | 2013-01-16 | 2014-11-12 | 浙江大学宁波理工学院 | 一种2-溴代甲基-4-羧酸乙酯噻唑的合成方法 |
| BR112021020864A2 (pt) | 2019-04-19 | 2021-12-14 | Ligand Pharm Inc | Formas cristalinas e métodos de produção de formas cristalinas de um composto |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003057669A1 (fr) * | 2001-12-28 | 2003-07-17 | Takeda Chemical Industries, Ltd. | Antagonistes du recepteur androgene |
-
2007
- 2007-06-12 WO PCT/JP2007/062194 patent/WO2007145349A2/en not_active Ceased
- 2007-06-12 AR ARP070102559A patent/AR061439A1/es not_active Application Discontinuation
- 2007-06-12 TW TW096121111A patent/TW200813007A/zh unknown
- 2007-06-12 PE PE2007000737A patent/PE20080938A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007145349A3 (en) | 2008-04-03 |
| AR061439A1 (es) | 2008-08-27 |
| WO2007145349A2 (en) | 2007-12-21 |
| TW200813007A (en) | 2008-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1123578T1 (el) | Ισοξαζολινες ναφθαλενιου ως παραγοντες καταπολεμησης ασπονδυλων επιβλαβων οργανισμων | |
| PE20091653A1 (es) | Derivados sustituidos de pirazol y su uso | |
| PE20081362A1 (es) | DERIVADOS MORFOLINO PIRIMIDINA COMO INHIBIDORES DE mTOR QUINASA Y PI3K | |
| PE20061439A1 (es) | DERIVADOS DE 2-AMIDO-6-AMINO-8-OXO-PURINA COMO MODULADORES DEL RECEPTOR Toll (TLR) | |
| AR059249A1 (es) | Compuesto amina trisustituido | |
| PE20090775A1 (es) | Nuevos derivados de biarilo | |
| PE20061084A1 (es) | Compuestos derivados de 2-ciano-3-(halo)alcoxi-bencenosulfonamida | |
| PE20080697A1 (es) | Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion | |
| PE20070427A1 (es) | Compuestos derivados de benzimidazoles sustituidos como inhibidores de tirosina quinasas | |
| PE20110875A1 (es) | Derivados de isoindol como inhibidores de bace | |
| PE20121282A1 (es) | Antagonistas de espiro-oxindol de mdm2 | |
| PE20090058A1 (es) | Compuestos carboxamida heterociclicos como inhibidores de la actividad akt | |
| PE20141203A1 (es) | Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas | |
| PE20061303A1 (es) | Composicion farmaceutica que comprende oxaprozina | |
| AR071609A1 (es) | Inhibidores ciclicos de 11(beta) -hidroxiesteroide deshidrogenasa 1 | |
| PE20120008A1 (es) | Derivados de fenoxi bencenosulfonamida | |
| AR039563A1 (es) | Derivados de 4-(imidazol-5-il)-2-(4-sulfoanilino)pirimidina con actividad inhibidora de cdk | |
| CL2008001668A1 (es) | Compuestos derivados de piperidin o piperazin carboxamida; composicion farmaceutica; y su uso en el tratamiento de la obesidad, hipercolesterolemia, dislipidemia, hipertrigliceridemia, higado graso, fibrosis hepatica, hepatitis, entre otras, mediadas por dgat. | |
| PE20091527A1 (es) | Derivados de piridazinona | |
| PE20110433A1 (es) | Antagonistas de la via hedgehog de ftalazina disustituida | |
| MX2010000658A (es) | Derivados de pirimidina 934. | |
| ATE374190T1 (de) | Tetrahydrochinazolinderivate als cfr-antagonisten | |
| PE20061316A1 (es) | Derivados de pirazol como antagonistas del receptor de progesterona | |
| CO6160324A2 (es) | Heterociclos sustituidos que contienen nitrogeno como inhibidores del receptor adp plaquetario | |
| BRPI0912171A8 (pt) | Composto ativador de receptor de glicocorticoide, e, composição |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |